Lisata Therapeutics, Inc. (LSTA) vs Medicus Pharma Ltd. Common Stock (MDCX)
A side-by-side comparison of Lisata Therapeutics, Inc. and Medicus Pharma Ltd. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LSTA
Lisata Therapeutics, Inc.
$1.16HealthcareDelayed quote: Oct 6, 2026, 1:52 PM EDT
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 1:47 PM EDT
Total return — LSTA vs MDCX
growth of $100 · dividends reinvested · last 2yLSTA -56.7% (-34.2%/yr)MDCX -93.7% (-74.9%/yr)LSTA compounded faster over this window
Log scale — wide-divergence pair
LSTA MDCX
LSTA vs MDCX: by the numbers
- •LSTA is the larger company ($11M vs $10M market cap).
- •Both run net losses; MDCX's is the smaller (0.00% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | LSTA | MDCX |
|---|---|---|
| P/S ratio | 105.63 | N/A |
| P/B ratio | 1.28 | N/A |
Profitability
| Metric | LSTA | MDCX |
|---|---|---|
| Gross margin | 14.12% | 0.00% |
| Operating margin | -10711.18% | 0.00% |
| Net margin | -14621.00% | 0.00% |
| ROE | -177.35% | N/A |
| ROIC | -204.32% | -269.16% |
Growth (annualized)
| Metric | LSTA | MDCX |
|---|---|---|
| Total return CAGR (5Y) | -40.75% | N/A |
Go deeper
Dig into the metrics
Lisata Therapeutics ROEMedicus Pharma Ltd. Common Stock ROELisata Therapeutics operating marginMedicus Pharma Ltd. Common Stock operating marginLisata Therapeutics revenue growthMedicus Pharma Ltd. Common Stock revenue growthLisata Therapeutics free cash flowMedicus Pharma Ltd. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.